See-Wei Low
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
See-Wei Low has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Fabien Maldonado
Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
6 shared publications - Justin Z. Lee
Department of Internal Medicine, University of Arizona, 1501 N. Campbell Avenue, RM 6336, Tucson, AZ, 85724-5040, USA
4 shared publications - Eric L. Grogan
Vanderbilt University Medical Center, Nashville, Tennessee
3 shared publications - Kwan Seung Lee
Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA
3 shared publications - Otis B. Rickman
Vanderbilt Univ Medl Ctr, Nashville, TN, United States
3 shared publications - Rafael Paez
Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, USA
3 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by Elsevier in SSRN Electronic Journal
The Impact of Mobile Cone Beam CT Guidance on Transbronchial Lung Cryobiopsy Safety, Radiation Exposure, and Diagnostic Yield
Background Identifying the cause of interstitial lung disease (ILD) remains difficult. While surgical lung biopsy remains the gold standard, transbronchial lung cryobiopsy (TBLC) represents a minimally invasive alternative with an improved safety profile and acceptable diagnostic accuracy. Real time imaging with cone beam computed tomography (CBCT) guidance may improve TBLC, but data supporting this approach remains limited. We analyzed the safety profile of performing TBLC with mobile CBCT guidance and compared it to historical controls using other modalities. Methods We performed a retrospective, single center analysis of patients undergoing TBLC with mobile CBCT from June 2023 through July 2025 for ILD evaluation. The primary study end point was safety, defined as pneumothorax or pulmonary hemorrhage incidence. Radiation dose, ILD diagnosis, and change in patient management were secondary endpoints. Results 128 patients underwent TBLC with mobile CBCT. No complications occurred after TBLC. After transbronchial forceps biopsy, however, pneumothorax occurred in two patients, without the need for tube thoracostomy. Grade 2 bleeding occurred in one patient. Mean radiation exposure was 157±77mGy, which was less compared to fixed CBCT guidance (1171±309mGy) and comparable to 2D fluoroscopy (110±78mGy). 89% (114/128) of patients received a final diagnosis of a specific ILD, with 68% (87/128) starting at least one new medication. Conclusion TBLC with mobile CBCT guidance is safe and effective in facilitating diagnoses and management changes in ILD patients. Radiation exposure is decreased compared to fixed CBCT and comparable to 2D fluoroscopic guidance.
- 31 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe Impact of Mobile Cone Beam CT Guidance on Transbronchial Lung Cryobiopsy Safety, Radiation Exposure, and Diagnostic Yield
Background Identifying the cause of interstitial lung disease (ILD) remains difficult. While surgical lung biopsy remains the gold standard, transbronchial lung cryobiopsy (TBLC) represents a minimally invasive alternative with an improved safety profile and acceptable diagnostic accuracy. Real time imaging with cone beam computed tomography (CBCT) guidance may improve TBLC, but data supporting this approach remains limited. We analyzed the safety profile of performing TBLC with mobile CBCT guidance and compared it to historical controls using other modalities. Methods We performed a retrospective, single center analysis of patients undergoing TBLC with mobile CBCT from June 2023 through July 2025 for ILD evaluation. The primary study end point was safety, defined as pneumothorax or pulmonary hemorrhage incidence. Radiation dose, ILD diagnosis, and change in patient management were secondary endpoints. Results 128 patients underwent TBLC with mobile CBCT. No complications occurred after TBLC. After transbronchial forceps biopsy, however, pneumothorax occurred in two patients, without the need for tube thoracostomy. Grade 2 bleeding occurred in one patient. Mean radiation exposure was 157±77mGy, which was less compared to fixed CBCT guidance (1171±309mGy) and comparable to 2D fluoroscopy (110±78mGy). 89% (114/128) of patients received a final diagnosis of a specific ILD, with 68% (87/128) starting at least one new medication. Conclusion TBLC with mobile CBCT guidance is safe and effective in facilitating diagnoses and management changes in ILD patients. Radiation exposure is decreased compared to fixed CBCT and comparable to 2D fluoroscopic guidance.
- 27 August 2024
- Published by Elsevier in Cancer Epidemiology
- Vol. 92, 102652
Lung cancer mortality trends and disparities: A cross-sectional analysis 1999–2020
- 27 August 2024
- Published by Elsevier in Cancer Epidemiology
- Vol. 92, 102652
Lung cancer mortality trends and disparities: A cross-sectional analysis 1999–2020
- Open Access
- 19 March 2024
- Published by Elsevier in CHEST Pulmonary
- Vol. 2 (3)
Navigational Bronchoscopy vs CT Scan-Guided Transthoracic Needle Biopsy for the Diagnosis of Indeterminate Lung Nodules
- 19 March 2024
- Published by Elsevier in CHEST Pulmonary
- Vol. 2 (3)
Open AccessNavigational Bronchoscopy vs CT Scan-Guided Transthoracic Needle Biopsy for the Diagnosis of Indeterminate Lung Nodules
- Open Access
- 26 December 2023
- Published by Elsevier in CHEST Pulmonary
- Vol. 2 (1)
The Lung Cancer Prediction Model “Stress Test”
- 26 December 2023
- Published by Elsevier in CHEST Pulmonary
- Vol. 2 (1)
Open AccessThe Lung Cancer Prediction Model “Stress Test”
- Open Access
- 15 May 2023
- Published by Elsevier in CHEST Pulmonary
- Vol. 1 (1)
Impact of the Social Vulnerability Index on Pulmonary Embolism Mortality
- 15 May 2023
- Published by Elsevier in CHEST Pulmonary
- Vol. 1 (1)
Open AccessImpact of the Social Vulnerability Index on Pulmonary Embolism Mortality
- 20 December 2022
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 30 (4) , 321-327
Feasibility and Efficacy of a Non-Opioid Based Pain Management After Medical Thoracoscopy
Background: Prescription opioids are a major cause of the opioid epidemic. Despite the minimally invasive nature of medical thoracoscopy (MT), data on the efficacy of non-opioid-based pain control after MT is lacking. The purpose of this study is to assess the feasibility and efficacy of a non-opioid-based pain management strategy in patients who underwent MT. Methods: We performed a retrospective analysis of all patients who underwent MT in the Mayo Clinic (Minnesota and Arizona) outpatient setting. We assessed their pain level and the need for analgesia post-MT from August 1, 2019, to May 24, 2021. Results: Forty patients were included. In the first 24 hours, 5/40 (12.5%) reported no pain. Twenty-eight patients out of 40 (70%) reported minor pain (pain scale 1-3), and 7/40 (17.5%) reported moderate pain (pain scale 4-6). No patients reported severe pain. Twenty-two out of 35 patients who experienced discomfort (63%) required acetaminophen, 6/35 patients (17%) required nonsteroidal anti-inflammatory drug, and 7/35 patients (20%) did not require analgesia. Of the 7 patients who had moderate pain, 5 (71%) reported that the moderate pain improved to mild at 72 hours post-MT. Zero patients required opioids, and none reported contacting any provider to manage the pain post-MT. Fourteen patients (78%) who had both parietal pleural biopsies and tunneled pleural catheter placed reported minor pain, 3 patients (17%) reported moderate pain, and 1 patient (6%) experienced no discomfort. Conclusion: MT is well-tolerated by patients with non-opioid-based pain management strategy as needed if there is no absolute contraindication.
- 20 December 2022
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 30 (4) , 321-327
Feasibility and Efficacy of a Non-Opioid Based Pain Management After Medical Thoracoscopy
Background: Prescription opioids are a major cause of the opioid epidemic. Despite the minimally invasive nature of medical thoracoscopy (MT), data on the efficacy of non-opioid-based pain control after MT is lacking. The purpose of this study is to assess the feasibility and efficacy of a non-opioid-based pain management strategy in patients who underwent MT. Methods: We performed a retrospective analysis of all patients who underwent MT in the Mayo Clinic (Minnesota and Arizona) outpatient setting. We assessed their pain level and the need for analgesia post-MT from August 1, 2019, to May 24, 2021. Results: Forty patients were included. In the first 24 hours, 5/40 (12.5%) reported no pain. Twenty-eight patients out of 40 (70%) reported minor pain (pain scale 1-3), and 7/40 (17.5%) reported moderate pain (pain scale 4-6). No patients reported severe pain. Twenty-two out of 35 patients who experienced discomfort (63%) required acetaminophen, 6/35 patients (17%) required nonsteroidal anti-inflammatory drug, and 7/35 patients (20%) did not require analgesia. Of the 7 patients who had moderate pain, 5 (71%) reported that the moderate pain improved to mild at 72 hours post-MT. Zero patients required opioids, and none reported contacting any provider to manage the pain post-MT. Fourteen patients (78%) who had both parietal pleural biopsies and tunneled pleural catheter placed reported minor pain, 3 patients (17%) reported moderate pain, and 1 patient (6%) experienced no discomfort. Conclusion: MT is well-tolerated by patients with non-opioid-based pain management strategy as needed if there is no absolute contraindication.
- 7 February 2022
- Published by Springer Nature in Lung
- Vol. 200 (2) , 149-151
Cryobiopsies for Diffuse Parenchymal Lung Disease in Acutely Ill Patients: Just Because We Can Does Not Mean We Should
- 7 February 2022
- Published by Springer Nature in Lung
- Vol. 200 (2) , 149-151
Cryobiopsies for Diffuse Parenchymal Lung Disease in Acutely Ill Patients: Just Because We Can Does Not Mean We Should